Intervention

Albuterol sulfate

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions3

Lead sponsors shown4

Clinical trials

4 shown

Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)NCT07721922 · 2026-09-01

NOT_YET_RECRUITING

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsNCT06052267 · 2023-08-30

ACTIVE_NOT_RECRUITING

Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPINCT00565591 · 2007-11-01

(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)NCT00394329 · 2006-11-01

Common conditions

Asthma2 Allergic Asthma1 COPD Exacerbation1

Leading sponsors

Milton S. Hershey Medical Center1 Respirics Inc.1 Teva Branded Pharmaceutical Products R&D LLC1 University of Tennessee Graduate School of Medicine1

Trial status mix

COMPLETED2

ACTIVE_NOT_RECRUITING1

NOT_YET_RECRUITING1

Phase mix

PHASE32

PHASE11

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.